CAN103

· CANbridge (Suzhou) Bio-pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAN103, covering 2022-07-27 to 2022-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease [Phase 1, Phase 2]